A duplex real-time fluorescent quantitative PCR method for simultaneous and rapid detection of Actinobacillus

Yu-Jie Ren1, Hua Lin2, Dao-Jian Yu3

  • 1Science and Technology Research Center of China Customs, Beijing, China.

PubMed

Insights

A new duplex real-time PCR assay simultaneously detects Actinobacillus pleuropneumoniae (APP) and influenza A (H1N1) virus in swine. This rapid, portable test aids in diagnosing complex respiratory co-infections for better disease management.

Area of Science:

  • Veterinary Diagnostics
  • Molecular Biology
  • Animal Health

Background:

  • Swine respiratory disease is often caused by co-infections, complicating diagnosis and control.
  • Actinobacillus pleuropneumoniae (APP) and influenza A (H1N1) virus are common pathogens involved in swine respiratory disease.
  • Accurate and rapid diagnostic tools are crucial for managing swine respiratory outbreaks.

Purpose of the Study:

  • To develop and validate a novel duplex TaqMan real-time PCR assay for simultaneous detection of APP and H1N1.
  • To optimize the assay for a portable automated detection system (Coyote Flash10).
  • To provide a rapid, point-of-care diagnostic solution for swine respiratory co-infections.

Main Methods:

  • Developed a duplex TaqMan real-time PCR assay targeting the apxIVA gene of APP and the M gene of H1N1.
  • Utilized porcine RNase P as an internal control.
  • Validated the assay using recombinant plasmid standards and simulated clinical matrices.

Main Results:

  • Achieved high sensitivity (1 copy/μL) and linearity (R² > 0.99) for both targets.
  • Demonstrated robust quantification and excellent repeatability (intra-assay CV <3%) and specificity.
  • The assay provided results within one hour, with detection limits of 10,000-fold for APP and 100-fold for H1N1 in simulated samples.

Conclusions:

  • The developed duplex real-time PCR assay is a rapid and specific tool for simultaneous detection of APP and H1N1 in swine.
  • The portable nature of the assay makes it suitable for on-farm surveillance and differential diagnosis.
  • Further validation with authentic clinical samples is recommended to confirm clinical utility.